This site is intended for healthcare professionals only
LoginRegister
WHO Alert Spurs Indias Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament InformedWHO Alert Spurs India's Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited,...
CDSCO Panel Seeks Protocol Revisions in Levim Lifetechs Teriparatide Biosimilar StudyCDSCO Panel Seeks Protocol Revisions in Levim Lifetech's Teriparatide Biosimilar Study
Health Ministry Mulls Extension for Pharma Firms to Comply with Revised Schedule M GMP NormsSame Brand Name Used for Multiple Drugs: Govt Panel Calls for Stakeholder Consultation
Over 4000 medical device manufacturing sites licensed since 2021, Minister tells ParliamentOver 4000 medical device manufacturing sites licensed since 2021, Minister tells Parliament
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib CapsulesProduct basket under Pradhan Mantri Bhartiya Janaushadhi Yojna has 2110 medicines: Minister
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar DrugsBiocon to make Biocon Biologics a wholly owned arm
Senores Pharma launches Deferiprone Tablets in USSenores Pharma gets Philippine FDA approval for basket of 10 products
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar DrugsBiocon Pharma gains tentative USFDA nod for Parkinson's disease capsules
ITAT Delhi Grants Relief to Pharmacy Owner, Deletes Rs 19.68 Lakh Addition on Demonetisation-Era SalesHaryana Pharmacy Council to Deregister Pharmacists Over Illegal Sale of Psychotropic Drugs, MTP Kits
Delhi HC Clears Zydus Cancer Drug ZRC-3276 Despite BMS Patent ClaimSemaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to...
Ipca Pharma incorporates new wholly owned arm in Federal Republic of GermanyIpca Labs receives 3 USFDA observations for Tarapur facility
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma
X